Disruptive innovations sometimes come directly from the development of a novel enabling technology. In other cases, however, they result from focusing on a known problem using a different lens. Such creativity underlies new research suggesting the potential for harnessing the microbiome to treat neurological disorders.
A Dec. 1 paper in Cell offers mechanistic proof of signaling between gut and brain in Parkinson’s Disease (PD). It...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?